4//SEC Filing
Bellerophon Therapeutics, Inc. 4
Accession 0001600132-17-000056
CIK 0001600132operating
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:04 PM ET
Size
4.5 KB
Accession
0001600132-17-000056
Insider Transaction Report
Form 4
Schoeps Megan
Principal Financial Officer
Transactions
- Tax Payment
Common Stock
2017-05-17$1.40/sh−10,459$14,683→ 18,248 total
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001600132
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:04 PM ET
- Size
- 4.5 KB